17 alpha-hydroxyprogesterone caproate has been researched along with raloxifene hydrochloride in 1 studies
Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (raloxifene hydrochloride) | Trials (raloxifene hydrochloride) | Recent Studies (post-2010) (raloxifene hydrochloride) |
---|---|---|---|---|---|
517 | 88 | 251 | 2,818 | 481 | 810 |
Protein | Taxonomy | 17 alpha-hydroxyprogesterone caproate (IC50) | raloxifene hydrochloride (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.0053 | |
Gastric inhibitory polypeptide receptor | Homo sapiens (human) | 0.0004 | |
Estrogen receptor beta | Homo sapiens (human) | 0.1297 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Izutsu, T; Sugiyama, T | 1 |
1 review(s) available for 17 alpha-hydroxyprogesterone caproate and raloxifene hydrochloride
Article | Year |
---|---|
[Hormone therapy for uterine corpus cancer--introduction].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Leuprolide; Medroxyprogesterone Acetate; Raloxifene Hydrochloride; Receptors, Progesterone; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome | 2004 |